Article Details
Retrieved on: 2018-03-16 22:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Oppenheimer & Company Inc decreased its stake in Genomic Health Inc (GHDX) by 27.03% based on its latest 2017Q3 regulatory filing with the SEC. Oppenheimer & Company Inc sold 26,533 shares as the company's stock rose 1.41% with the market. The institutional investor held 71,626 shares of the ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here